These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8644190)

  • 1. Proposal for an International Registry and Depository of Hyperacute Rejection after kidney transplantation.
    Doxiadis II; Claas FH
    Transplant Proc; 1996 Feb; 28(1):225. PubMed ID: 8644190
    [No Abstract]   [Full Text] [Related]  

  • 2. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA antigens in kidney allograft rejection.
    Sujirachato K; Chiewsilp P; Jirasiritham S; Mongkolsuk T; Sumethkul V
    Transplant Proc; 1996 Jun; 28(3):1272. PubMed ID: 8658656
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of HLA-DR incompatibilities on kidney graft function and on the number of rejection treatments. The Dutch Study Group of Renal Transplantation.
    Groenewoud AF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):683-4. PubMed ID: 3274840
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term kidney graft outcome based on HLA-DRB1 matching.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi MO; Ohshima S; Ikoma F
    Transplant Proc; 1994 Aug; 26(4):1884-6. PubMed ID: 7915054
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular level HLA mismatches in UNOS "zero-mismatched" kidney transplants.
    Cook DJ; Roeske L; Hodge EE; Goldfarb D; Flechner SM; Dennis VW; Novick AC
    Transplant Proc; 1997; 29(1-2):1401-2. PubMed ID: 9123354
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation.
    Pfeffer PF; Foerster A; Frøysaker T; Thorsby E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):691-2. PubMed ID: 3274844
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of HLA matching on the results of kidney transplantation (81 case reports).
    De-Lin G; Lu-Lin M; Bu-Lang H
    Transplant Proc; 1998 Nov; 30(7):3498-9. PubMed ID: 9838534
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of flow cytometry cross-matching results on the outcome of cadaveric kidney transplantation.
    Wahlberg J; Bengtsson M; Bergström C; Gannedahl G; Festin R; Lewen G; Frödin L
    Transplant Proc; 1994 Jun; 26(3):1752-3. PubMed ID: 8030118
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal transplant graft survival results and HLA-A,B, DR mismatching.
    Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
    Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial HLA matching: its phase of impact on graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 16. Crossmatch with donor skin: characterization of alloantibodies and correlation with early kidney rejection.
    Moraes JR; Moraes ME; Luo Y; Peters PC; Sagalowsky A; Dawidson I; Lu C; Stastny P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):471-2. PubMed ID: 1990588
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term success rate of HLA-DRB1 compatible kidney transplants.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi M; Ohshima S; Ikoma F
    Transplant Proc; 1993 Dec; 25(6):3056-9. PubMed ID: 8266451
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
    Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
    Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402?
    Lomago J; Jelenik L; Zern D; Howe J; Martell J; Zeevi A; Duquesnoy RJ
    Hum Immunol; 2010 Feb; 71(2):176-8. PubMed ID: 19963027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.